Acadia stock rallies on drug news as Roivant also climbs, while Leslie’s, Theseus shares plunge and more moving stocks

by user

[ad_1]

Here are some of the biggest movers ahead of Friday’s market open:

Stock gainers:

Acadia Pharmaceuticals Inc.’s stock
ACAD,
-0.23%

surged 18% in premarket trading after the company expanded drug rights to a treatment for a rare neurological disorder.

Shares of Roivant Sciences Ltd.
ROIV,
+1.58%

rallied nearly 10% following a Wall Street Journal report the biotech drug maker was close to the sale of an ulcerative colitis drug to Roche Holding
ROG,
+1.25%

JPMorgan Chase & Co. shares
JPM,
+0.49%

rose 0.6% in premarket trading ahead of the Wall Street bank’s second-quarter results due Friday.

Stock decliners:

Theseus Pharmaceuticals Inc. shares
THRX,
-3.74%

plummeted 64% as the drug maker announced it halted development of a cancer drug candidate.

Shares of Leslie’s Inc. fell 24% after the spa and pool supplies retailer announced preliminary quarterly results below expectations, dialed down its 2023 outlook, and announced a CFO transition.

Shares of Nokia Oyj
NOK,
+1.64%

dropped nearly 10% in premarket trading after the Finnish telecom equipment maker lowered its full-year outlook after preliminary second-quarter results. Shares of its Swedish rival Ericsson AB
ERIC,
+1.77%

fell 8.5% after meeting expectations with its results, but giving lackluster guidance.

Shares of Caribou Biosciences Inc.
CRBU,
+4.90%

were down 4% after the biopharma company said it had begun a $100 million share offering.

[ad_2]

Source link

Related Posts

Leave a Review

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy